Go Pro
NASDAQ:HCACR

Healthcare Capital Acquisition Corp. I Rights (HCACR) Stock Price, News & Analysis

$0.25 0.00 (-0.40%)
Closing price 03:42 PM Eastern
Extended Trading
$0.25 +0.00 (+0.40%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Healthcare Capital Acquisition Corp. I Rights Stock (NASDAQ:HCACR)

Advanced

Key Stats

Today's Range
$0.25
$0.25
50-Day Range
$0.22
$0.32
52-Week Range
$0.20
$0.35
Volume
8,019 shs
Average Volume
113,040 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Healthcare Capital Acquisition Corp. I Rights (NASDAQ: HCACR) represent the rights issued in connection with Healthcare Capital Acquisition Corp., a special purpose acquisition company (SPAC) formed to effect a business combination with one or more businesses in the healthcare sector. As a blank-check company, its principal objective is to identify, negotiate and complete an acquisition, merger or similar transaction that will result in a operating public company focused on healthcare-related products and services.

The company’s primary activities are raising capital through its initial public offering and related unit structure, maintaining that capital in trust pending a qualifying business combination, and pursuing potential targets across healthcare subsectors such as pharmaceuticals, biotechnology, medical devices, healthcare services and health technology. The HCACR ticker denotes the separate tradeable rights that were distributed as part of the SPAC’s offering; these rights are distinct from the company’s public shares and warrants and are governed by the terms set forth in its offering documents.

As a SPAC, Healthcare Capital Acquisition Corp. has limited operating history as a standalone business and relies on its sponsor and management team to source and execute a transaction. The company is listed on the Nasdaq and is subject to U.S. securities regulation and disclosure requirements; more detailed information about its leadership, sponsor, proposed transaction criteria and the specific rights terms is available in its SEC filings and the prospectus distributed at the time of its offering.

Investors interested in HCACR should review the company’s offering documents and periodic reports to understand the rights’ exercise provisions, expiration terms and any contingencies related to a proposed business combination. Because SPACs are structured to pursue an acquisition rather than to operate a business prior to a deal, their securities—including rights—carry considerations distinct from operating companies, and prospective investors are advised to consult the company’s publicly filed disclosures for full details.

AI Generated. May Contain Errors.

Receive HCACR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthcare Capital Acquisition Corp. I Rights and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCACR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

HCACR Stock Analysis - Frequently Asked Questions

Healthcare Capital Acquisition Corp. I Rights' stock was trading at $0.25 on February 13, 2026. Since then, HCACR shares have decreased by 0.4% and is now trading at $0.2490.

Shares of HCACR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:HCACR
CIK
2079013
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:HCACR) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners